80
43
Growth Score 80 in past quarter
-6 pts
Heat Score 43 in past quarter
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
999859
Detection of Barrett’s Esophagus
Acquired by 
LUCID DIAGNOSTICS INC.
About the Company
FDA cleared device for early detection of Barrett’s Esophagus and other Upper GI diseases such as cancer and H-pylori.
Opportunity to launch the FDA 510k clearedNon-endoscopic swallowable screening device for esophageal bottle-brush cellular retrieval for use with new Genome Sequencing diagnostic tests (Biomarkers) that are expected to become
mass "out-patient" screening tests used for the early detection of Barrett’s Esophagus and other diseases.